[SRNE] QoQ Quarter Result on 31-Mar-2018 [#Q1]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
10-May-2018
Financial Year
2018
Quarter
31-Mar-2018 [#Q1]
Profit Trend
QoQ- -362.16%
YoY- -41.23%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Revenue 6,929 4,105 3,913 6,246 20,407 121,910 4,665 30.08%
PBT -55,746 -50,380 -74,081 -33,574 -38,001 94,953 -16,137 128.00%
Tax -3,122 -826 -1,377 -948 -90,424 57,480 -1,398 70.60%
NP -49,776 -47,328 -73,864 -32,574 12,425 33,959 -14,187 130.37%
Tax Rate - - - - - -60.54% - -
Total Cost 56,705 51,433 77,777 38,820 7,982 87,951 18,852 107.95%
Ratio Analysis
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
NP Margin -718.37 -1,152.94 -1,887.66 -521.52 60.89 27.86 -304.12 77.08%
Per Share
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
EPS -0.41 -0.40 -0.73 -0.38 0.15 0.44 -0.20 61.16%
EPS Diluted -0.41 -0.40 -0.73 -0.38 0.15 0.44 -0.20 61.16%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.